BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10506823)

  • 21. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK; Leung CB; Chow KM; Cheng YL; Fung SK; Mak SK; Tang AW; Wong TY; Yung CY; Yung JC; Yu AW; Szeto CC;
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in blood pressure, proteinuria and renal hemodynamics in type I diabetes with manifestations of diabetic nephropathy after 2 months of captopril therapy].
    Komers R; Malý J; Simková R
    Cas Lek Cesk; 1993 Jun; 132(12):359-64. PubMed ID: 8343943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
    J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy.
    Csiky B; Kovács T; Wágner L; Vass T; Nagy J
    Nephrol Dial Transplant; 1999 Jan; 14(1):86-90. PubMed ID: 10052483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of antihypertensive therapy on the renal function in spontaneously hypertensive rats (SHR) with renal ablation].
    Kanazawa M; Abe K; Yasujima M; Yoshida K; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):33-44. PubMed ID: 2348572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril.
    Del Vecchio L; Pozzi M; Salvetti A; Maschio G; Fusaroli M; Rovati C; Antonucci F; Cascone C; Scanferla F; Panichi V; Sturani A; Locatelli F;
    J Nephrol; 2004; 17(2):261-9. PubMed ID: 15293527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of the ACE-inhibitor captopril on the blood pressure and kidney function of patients with essential and renal hypertension].
    Jansa U; Stein G; Günther K
    Z Gesamte Inn Med; 1991 Dec; 46(17):642-7. PubMed ID: 1776307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting nicardipine for elderly hypertensive patients: effect on diurnal variation of blood pressure.
    Harada T; Imamura T; Hara K; Sakai A; Fukui J; Kubo S; Fujiwara H; Shikuwa M; Tanioka Y; Yamasa T
    Clin Ther; 1994; 16(3):386-93. PubMed ID: 7923305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of intensive therapy combined with tonsillectomy in patients with IgA nephropathy.
    Hotta O; Taguma Y; Yoshizawa N; Oda T; Nishiyama J; Yusa N; Chiba S; Horigome I; Sudo K; Tomioka S
    Acta Otolaryngol Suppl; 1996; 523():165-8. PubMed ID: 9082770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nicardipine, alone or in combination with enalapril, in the therapy of arterial hypertension secondary to chronic nephropathy].
    Pecci G; Feriozzi S; Morabito S; Mavrikakis G; Roscia E; Simonetti BM; Pierucci A
    Clin Ter; 1989 Sep; 130(6):327-32. PubMed ID: 2572374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian blood pressure changes and cardiac abnormalities in IgA nephropathy.
    Szelestei T; Kovács T; Barta J; Nagy J
    Am J Nephrol; 1999; 19(5):546-51. PubMed ID: 10575181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.